SINGLETON J MATTHEW — SEC Form 4 filings
SEC reporting owner CIK 1243514. 7 Form 4 filings on record with FilingPulse; latest filed 2026-01-05.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-08-14 to 2026-01-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 5 filings — 68,786 shares, $4,576,470 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 16,000 shares @ $79.50 ($1,272,000) in Viking Therapeutics, Inc., filed 2024-10-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | Director | 7 | — | 11 legs · 68,786 sh · $4,576,470 | 13 |
Form 4 filings — SINGLETON J MATTHEW
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-05 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 3,150 @ $0 · Grant/award (A): 20,400 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Viking Therapeutics, Inc. (VKTX) | Grant/award (A): 18,800 (derivative) @ $0 | EDGAR |
| 2024-10-25 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 16,000 @ $4.48 · Sale (S): 16,000 @ $79.50 · Option exercise (M): 16,000 (derivative) @ $0 | EDGAR |
| 2024-09-20 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 10,300 @ $1.19 · Sale (S): 10,300 @ $69.50 · Option exercise (M): 10,300 (derivative) @ $0 | EDGAR |
| 2024-08-22 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 5,700 @ $1.19 · Sale (S): 5,700 @ $69.72 · Option exercise (M): 5,700 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 16,000 @ $3.33 · Sale (S): 2,500 @ $60.01 · Sale (S): 3,047 @ $61.13 · Sale (S): 4,509 @ $61.86 · Sale (S): 2,055 @ $63.15 · Sale (S): 2,388 @ $64.10 · +2 more | EDGAR |
| 2024-08-14 | 4 | Viking Therapeutics, Inc. (VKTX) | Option exercise (M): 20,786 @ $8 · Sale (S): 20,626 @ $57.52 · Sale (S): 160 @ $58.37 · Option exercise (M): 20,786 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1243514 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →